Yahoo Search Búsqueda en la Web

Resultado de búsqueda

  1. Hace 10 horas · In 1966, Parkman, Dr. Harry M. Meyer Jr. and their collaborators at the National Institutes of Health, including Maurice R. Hilleman, disclosed that they had perfected a vaccine to prevent rubella.

  2. 15 de abr. de 2024 · Maurice Hilleman and his colleagues developed an even weaker virus strain that led to an improved vaccine. This vaccine, called the Edmonston-Enders (formerly “Moraten”) strain has been the only measles vaccine used in the United States since 1968.

  3. Hace 1 día · While Krugman was conducting his research, geneticist Baruch Blumberg identified the “Australian antigen,” a surface marker on hepatitis B, which made screening for hepatitis B a possibility. Blumberg’s work was taken up by Maurice Hilleman of Merck Laboratories to create a hepatitis B vaccine from harvested surface antigens (Halpern, 2021).

  4. Hace 1 día · M. Meyer Jr. and their collaborat­ors at the National Institutes of Health, including Maurice R. Hilleman, disclosed that they had perfected a vaccine to prevent rubella. Dr. Parkman and Dr. Meyer assigned their patents to the NIH so the vaccines could be manufactur­ed, distribute­d and administer­ed promptly.

  5. Hace 10 horas · In 1966, Parkman, Dr. Harry M. Meyer Jr. and their collaborators at the National Institutes of Health, including Maurice R. Hilleman, disclosed that they had perfected a vaccine to prevent rubella. Parkman and Meyer assigned their patents to the NIH so the vaccines could be manufactured, distributed and administered promptly.

  6. Hace 5 días · In 1966, Parkman, Dr. Harry M. Meyer Jr. and their collaborators at the National Institutes of Health, including Maurice R. Hilleman, disclosed that they had perfected a vaccine to prevent rubella. Parkman and Meyer assigned their patents to the NIH so the vaccines could be manufactured, distributed and administered promptly.

  7. Hace 5 días · A special session moderated by NFID Medical Director Robert (H. Hopkins, Jr. MD, highlighted research from the next generation of vaccinologists, including Nginache Nampota-Nkomba, MBBS, MSc, 1st place recipient of the 2024 Maurice R. Hilleman Early-Stage Career Investigator Award, who presented her research on typhoid conjugate vaccine duration of immunity and booster responses in Malawian ...